135 related articles for article (PubMed ID: 20087922)
1. Molecular modeling studies on the human neuropeptide S receptor and its antagonists.
Dal Ben D; Antonini I; Buccioni M; Lambertucci C; Marucci G; Vittori S; Volpini R; Cristalli G
ChemMedChem; 2010 Mar; 5(3):371-83. PubMed ID: 20087922
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide S receptor: recent updates on nonpeptide antagonist discovery.
Dal Ben D; Antonini I; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R; Cristalli G
ChemMedChem; 2011 Jul; 6(7):1163-71. PubMed ID: 21452188
[TBL] [Abstract][Full Text] [Related]
4. Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonists.
Lavecchia A; Cosconati S; Novellino E
J Med Chem; 2005 Apr; 48(7):2480-92. PubMed ID: 15801838
[TBL] [Abstract][Full Text] [Related]
5. Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.
Zhang Y; Sham YY; Rajamani R; Gao J; Portoghese PS
Chembiochem; 2005 May; 6(5):853-9. PubMed ID: 15776407
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
Axe FU; Bembenek SD; Szalma S
J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
[TBL] [Abstract][Full Text] [Related]
7. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
[TBL] [Abstract][Full Text] [Related]
8. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
Bissantz C; Bernard P; Hibert M; Rognan D
Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
Yuzlenko O; Kieć-Kononowicz K
J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
[TBL] [Abstract][Full Text] [Related]
10. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
11. Expanding GPCR homology model binding sites via a balloon potential: A molecular dynamics refinement approach.
Kimura SR; Tebben AJ; Langley DR
Proteins; 2008 Jun; 71(4):1919-29. PubMed ID: 18175323
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of the peptide agonist-binding site in a neurokinin-2 receptor.
Chandrashekaran IR; Rao GS; Cowsik SM
J Chem Inf Model; 2009 Jul; 49(7):1734-40. PubMed ID: 19534508
[TBL] [Abstract][Full Text] [Related]
13. Simulations of a G protein-coupled receptor homology model predict dynamic features and a ligand binding site.
Wolf S; Böckmann M; Höweler U; Schlitter J; Gerwert K
FEBS Lett; 2008 Oct; 582(23-24):3335-42. PubMed ID: 18775703
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
[TBL] [Abstract][Full Text] [Related]
15. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
Zhorov BS; Ananthanarayanan VS
Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
[TBL] [Abstract][Full Text] [Related]
16. Peptide interactions with G-protein coupled receptors.
Marshall GR
Biopolymers; 2001; 60(3):246-77. PubMed ID: 11774230
[TBL] [Abstract][Full Text] [Related]
17. Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan binding.
Patny A; Desai PV; Avery MA
Proteins; 2006 Dec; 65(4):824-42. PubMed ID: 17034041
[TBL] [Abstract][Full Text] [Related]
18. Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor.
Evers A; Klabunde T
J Med Chem; 2005 Feb; 48(4):1088-97. PubMed ID: 15715476
[TBL] [Abstract][Full Text] [Related]
19. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design.
Gloriam DE; Foord SM; Blaney FE; Garland SL
J Med Chem; 2009 Jul; 52(14):4429-42. PubMed ID: 19537715
[TBL] [Abstract][Full Text] [Related]
20. PREDICT modeling and in-silico screening for G-protein coupled receptors.
Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
